Evidence map›Paper›PMID 34000646›Full record

ReviewNeuroImage. Clinical2021

Hybrid modelling for stroke care: Review and suggestions of new approaches for risk assessment and simulation of scenarios.

Tilda Herrgårdh, Vince I Madai, John D Kelleher, Rasmus Magnusson, Mika Gustafsson, Lili Milani, Peter Gennemark, Gunnar Cedersund

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in NeuroImage. Clinical, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06714097 (Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06714097 narecruitingnot on this mapstarted 2026, after this paper: background citation

Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)

TypeinterventionalSponsorFondazione I.R.C.C.S. Istituto Neurologico Carlo BestaRan2026 to 2027Enrolled20ConditionsStroke, Moyamoya Disease, Cerebral Amyloid AngiopathyArmsAI, healthy dialogue
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 6 countries.

Tilda HerrgårdhIntegrative Systems Biology, Department of Biomedical Engineering, Linköping University, 58185 Linköping, Sweden.
Vince I MadaiCharité Lab for Artificial Intelligence in Medicine - CLAIM, Charité University Medicine Berlin, Germany; School of Computing and Digital Technology, Faculty of Computing, Engineering and the Built Environment, Birmingham City University, Birmingham, UK.
John D KelleherADAPT Research Centre, Technological University Dublin, Ireland.
Rasmus MagnussonBioinformatics, Department of Physics, Chemistry and Biology, Linköping University, Sweden.
Mika GustafssonBioinformatics, Department of Physics, Chemistry and Biology, Linköping University, Sweden.
Lili MilaniEstonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.
Peter GennemarkIntegrative Systems Biology, Department of Biomedical Engineering, Linköping University, 58185 Linköping, Sweden; Drug Metabolism and Pharmacokinetics, Early Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Gunnar CedersundIntegrative Systems Biology, Department of Biomedical Engineering, Linköping University, 58185 Linköping, Sweden. Electronic address: gunnar.cedersund@liu.se.
Linköping University · SEBirmingham City University · GBTechnological University Dublin · IEUniversity of Tartu · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke is an example of a complex and multi-factorial disease involving multiple organs, timescales, and disease mechanisms. To deal with this complexity, and to realize Precision Medicine of stroke, mathematical models are needed. Such approaches include: 1) machine learning, 2) bioinformatic network models, and 3) mechanistic models. Since these three approaches have complementary strengths and weaknesses, a hybrid modelling approach combining them would be the most beneficial. However, no concrete approach ready to be implemented for a specific disease has been presented to date. In this paper, we both review the strengths and weaknesses of the three approaches, and propose a roadmap for hybrid modelling in the case of stroke care. We focus on two main tasks needed for the clinical setting: a) For stroke risk calculation, we propose a new two-step approach, where non-linear mixed effects models and bioinformatic network models yield biomarkers which are used as input to a machine learning model and b) For simulation of care scenarios, we propose a new four-step approach, which revolves around iterations between simulations of the mechanistic models and imputations of non-modelled or non-measured variables. We illustrate and discuss the different approaches in the context of Precision Medicine for stroke.

Indexed as

StrokeComputer SimulationHumansMachine LearningModels, TheoreticalRisk AssessmentBioinformaticsMachine learningMechanistic modellingPrecision medicineStroke

Identifiers

PMID34000646
PMCPMC8141769
OpenAlexW3160900712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.